
Value of pharmaceutical gross-to-net reduction in the U.S. 2019-2023
This statistic shows the total value of pharmaceutical manufacturers' gross-to-net reductions on medications in the United States from 2019 to 2023, in billion U.S. dollars. In 2023, rebates and discounts provided by manufacturers totaled some 334 billion dollars.